Cargando…
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
4-1BB is a T cell costimulatory receptor and a member of the tumor necrosis factor receptor superfamily. Here, we show that Galectin-3 (Gal-3) decreases the cellular response to its ligand (4-1BBL). Gal-3 binds to both soluble 4-1BB (s4-1BB) and membrane-bound 4-1BB (mem4-1BB), without blocking co-b...
Autores principales: | Nielsen, Morten Aagaard, Juul-Madsen, Kristian, Stegmayr, John, Gao, Chao, Mehta, Akul Y., Greisen, Stinne Ravn, Kragstrup, Tue Wenzel, Hvid, Malene, Vorup-Jensen, Thomas, Cummings, Richard D., Leffler, Hakon, Deleuran, Bent Winding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263355/ https://www.ncbi.nlm.nih.gov/pubmed/35812455 http://dx.doi.org/10.3389/fimmu.2022.915890 |
Ejemplares similares
-
Galectin‐3 interacts with PD‐1 and counteracts the PD‐1 pathway‐driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis
por: Pedersen, Kathrine, et al.
Publicado: (2022) -
A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients
por: Kragstrup, Tue W, et al.
Publicado: (2013) -
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression
por: Kragstrup, Tue Wenzel, et al.
Publicado: (2016) -
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’
por: Greisen, Stinne Ravn, et al.
Publicado: (2014) -
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts
por: Nielsen, Morten A., et al.
Publicado: (2023)